Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 6:21:100704.
doi: 10.1016/j.conctc.2021.100704. eCollection 2021 Mar.

Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder

Breanne E Biondi  1 , Subhasis Mohanty  1 , Brent Vander Wyk  2 , Ruth R Montgomery  3 , Albert C Shaw  1 , Sandra A Springer  1   4
Affiliations

Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder

Breanne E Biondi et al. Contemp Clin Trials Commun. .

Abstract

Background: Opioid use disorder (OUD) negatively impacts the HIV continuum of care for persons living with HIV. Medication treatment for OUD (MOUD) may have differential biological effects in individuals with HIV and OUD. To address the question of modulation of immune responses by MOUDs, we describe state of the art systems biology approaches to carry out the first prospective, longitudinal study of persons with and without HIV infection with OUD initiating MOUD.

Methods: A prospective cohort study of persons with DSM-5 diagnosed OUD who are living with and without HIV infection and initiating treatment with methadone or buprenorphine is underway to assess biological effects of these medications on immunobiological outcomes.

Results: We describe the recruitment, laboratory, and statistical methods of this study as well as the protocol details. Of those screened for enrollment into the study, 468 (36%) were eligible and 135 were enrolled thus far. Retention through month 6 has been high at 80%.

Conclusions: This study will use state of the art systems biology approaches to carry out the first prospective, longitudinal studies of persons living with and without HIV with DSM-5 OUD initiating treatment with MOUD.

Keywords: Buprenorphine; HIV; Medication treatment for opioid use disorder; Methadone; Opioid use disorder.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to report related to this research.

Figures

Fig. 1
Fig. 1
MAT BIO - Study enrollment flow chart, through 03/13/20.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ahmad F.B. National Center for Health Statistics; 2020. Provisional drug overdose death counts.
    1. Rudd R.S.P., David F., Scholl L. Increases in drug and opioid-involved overdose deaths — United States, 2010–2015. MMWR Morb. Mortal. Wkly. Rep. 2016;65(50–51):1445–1452. - PubMed
    1. SAMHSA Medication-assisted treatment. 2018. https://www.samhsa.gov/medication-assisted-treatment
    1. Schuckit M.A. Treatment of opioid-use disorders. N. Engl. J. Med. 2016;375(4):357–368. - PubMed
    1. Global Commission on Drug Policy . October 30, 2014. Taking Control: Pathways to Drug Policies That Work.https://www.globalcommissionondrugs.org/wp-content/uploads/2016/03/GCDP_... Geneva, Switzerland.

LinkOut - more resources